Erdmann, Erland

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet

Diabetes Treatment and ManagementPeroxisome Proliferator-Activated Receptors

Cited by 4,129

Unchanged Protein Levels of SERCA II and Phospholamban but Reduced Ca 2+ Uptake and Ca 2+ -ATPase Activity of Cardiac Sarcoplasmic Reticulum From Dilated Cardiomyopathy Patients Compared With Patients With Nonfailing Hearts

Schwinger, R. H. G., Böhm, M., Schmidt, U., Karczewski, P., Bavendiek, U., Flesch, M., Krause, E.-G., & Erdmann, E. (1995) · Circulation

Cardiac electrophysiology and arrhythmiasCardiomyopathy and Myosin Studies

Cited by 395

Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population

Doehner, W., Erdmann, E., Cairns, R., Clark, A. L., Dormandy, J. A., Ferrannini, E., & Anker, S. D. (2012) · International Journal of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 215

Effects of ribose on exercise-induced ischaemia in stable coronary artery disease

Pliml, W., von Arnim, T., Stablein, A., Erdmann, E., Zimmer, H.-G., & Hofmann, H. (1992) · The Lancet

Cardiac Ischemia and ReperfusionHeart rate and cardiovascular health

Cited by 92

Alcohol and the risk of myocardial infarction

Flesch, M., Rosenkranz, S., Erdmann, E., & Böhm, M. (2001) · Basic Research in Cardiology

Alcohol Consumption and Health EffectsCardiovascular Health and Risk Factors

Cited by 87

Ten‐year observational follow‐up of PROactive : a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes

Erdmann, E., Harding, S., Lam, H., & Perez, A. (2016) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 80

Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure

Hoppe, U. C., Freemantle, N., Cleland, J. G. F., Marijianowski, M., & Erdmann, E. (2007) · Diabetes Care

Cardiac pacing and defibrillation studiesHeart Failure Treatment and Management

Cited by 43

NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope

Pfister, R., Hagemeister, J., Esser, S., Hellmich, M., Erdmann, E., & Schneider, C. A. (2012) · International Journal of Cardiology

Cardiovascular Syncope and Autonomic DisordersHeart Failure Treatment and Management

Cited by 35

Antiadrenergic effect of carbachol but not of adenosine on contractility in the intact human ventricle in vivo

Koglin, J., Böhm, M., von Scheidt, W., Stäblein, A., & Erdmann, E. (1994) · Journal of the American College of Cardiology

Adenosine and Purinergic SignalingPhosphodiesterase function and regulation

Cited by 21